^sup 18^F-FLT PET for Visualization of Laryngeal Cancer: Comparison with ^sup 18^F-FDG PET

From: The Journal of Nuclear Medicine | Date: February 1, 2004| Author: Cobben, David C P; Maas, Bram; Vaalburg, Willem; Et al | Copyright information

The feasibility of ^sup 18^F-3'-fluoro-3'-deoxy-L-thymidine PET (FLT PET) for detecting laryngeal cancer was investigated and compared with ^sup 18^F-FDG PET. Methods: Eleven patients diagnosed with or strongly suspected of having recurrent laryngeal cancer and 10 patients with histologically proven primary laryngeal cancer underwent attenuation-corrected ^sup 18^F-FLT PET imaging 60 min after injection of a median of 213 MBq (range, 175-400 MBq) ^sup 18^F-FLT and attenuation-corrected ^sup 1...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Comparative Evaluation of ^sup 18^F-FDG PET and ^sup 67^Ga Scintigraphy in Patients with Sarcoidosis
The Journal of Nuclear Medicine ; ^sup 67^Ga scintigraphy has been used for years in sarcoidosis for diagnosis and the extent of the disease. However, little information is available on the comparison of ^sup 18^F-FDG PET and ^sup 67^Ga scintigraphy in the assessment of sarcoidosis. The purpose of this study was to compare the
Is ^sup 18^F-3'-Fluoro-3'-Deoxy-L-Thymidine Useful for the Staging and Restaging of Non-Small Cell Lung Cancer?
The Journal of Nuclear Medicine ; The objective of this study was to compare ^sup 18^F-3'-fluoro-3'-deoxy-L-thymidine (FLT) PET with clinical TNM staging, including that by ^sup 18^F-FDG PET, in patients with non-small cell lung cancer (NSCLC). Methods: Patients with NSCLC underwent whole-body ^sup 18^F-FDG PET and whole-body ^sup
Usefulness of Fasting ^sup 18^F-FDG PET in Identification of Cardiac Sarcoidosis
The Journal of Nuclear Medicine ; Cardiac PET using ^sup 18^F-FDG under fasting conditions (fasting ^sup 18^F-FDG PET) is a promising technique for identification of cardiac sarcoidosis and assessment of disease activity. The aim of this study was to investigate the usefulness of fasting ^sup 18^F-FDG PET in detecting inflammatory
^sup 18^F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: A meta-analysis
The Journal of Nuclear Medicine ; PET using ^sup 18^F-FDG is increasingly used for the diagnosis and grading of tumors. Several studies have been performed that evaluate the diagnostic and grading performance of ^sup 18^F-FDG PET for soft-tissue sarcoma, but each study has had a limited sample size. Therefore, we undertook a
Small-Animal PET of Melanocortin 1 Receptor Expression Using a ^sup 18^F-Labeled [alpha]-Melanocyte-Stimulating Hormone Analog
The Journal of Nuclear Medicine ; ^sup 18^F-Labeled small synthetic peptides have emerged as attractive probes for imaging various molecular targets with PET. The α-melanocyte-stimulating hormone 945;-MSH) receptor (melanocortin type 1 receptor [MC1R]) is overexpressed in most murine and human melanomas. It is a promising